ASSOCIATION OF FUROSEMIDE VS TORSEMIDE WITH FIVE-YEAR NEUROCOGNITIVE OUTCOMES IN PATIENTS WITH HEART FAILURE

被引:0
|
作者
Miller, Alec [1 ]
Jacobs, Mark [1 ]
Skopicki, Hal A. [1 ]
Kalogeropoulos, Andreas P. [1 ]
机构
[1] Stony Brook Univ Hosp, Stony Brook, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1768-162
引用
收藏
页码:736 / 736
页数:1
相关论文
共 50 条
  • [11] BIOAVAILABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TORSEMIDE AND FUROSEMIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    VARGO, DL
    KRAMER, WG
    BLACK, PK
    SMITH, WB
    SERPAS, T
    BRATER, DC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (06) : 601 - 609
  • [12] Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis
    Miles, Jeremy A.
    Hanumanthu, Balaram K.
    Patel, Kavisha
    Chen, Michelle
    Siegel, Robert M.
    Kokkinidis, Damianos G.
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2019, 20 (06) : 379 - 388
  • [13] Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis
    Kido, Kazuhiko
    Shimizu, Mikiko
    Hashiguchi, Masayuki
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (03) : 432 - 438
  • [14] Clinical Outcomes With Furosemide Versus Torsemide in Patients With Heart Failure: An Updated Systematic Review and Meta-Analysis
    Siddiqi, Ahmed Kamal
    Javaid, Hira
    Ahmed, Mushood
    Dhawadi, Siwar
    Batool, Laiba
    Zahid, Maheen
    Muslim, Muhammad Osama
    Naeem, Khadija
    Mahmood, Fizza
    Hussain, Abbas
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (11)
  • [15] Five-year mortality in congestive heart failure patients with undiagnosed diabetes
    Flores, J.
    Comin, J.
    Cano, J. F.
    Benaiges, D.
    Chillaron, J. J.
    Goday, A.
    Bruguera, J.
    Fernandez, M.
    Puig, J.
    [J]. DIABETOLOGIA, 2007, 50 : S502 - S502
  • [16] Torsemide Versus Furosemide in Heart Failure Patients: Insights From Duke University Hospital
    Mentz, Robert J.
    Buggey, Jonathan
    Fiuzat, Mona
    Ersboll, Mads K.
    Schulte, Phillip J.
    DeVore, Adam D.
    Eisenstein, Eric L.
    Anstrom, Kevin J.
    O'Connor, Christopher M.
    Velazquez, Eric J.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 65 (05) : 438 - 443
  • [17] The use of Torsemide versus Furosemide in Patients with Heart Failure, a Systematic Review and Meta Analysis
    Abraham, Bishoy
    Kirillova, Venera V.
    Fransawyalkomos, Mina
    Megaly, Michael
    Sous, Mina
    Saad, Marwan
    Fraser, Robert
    Topf, Joel
    Goldsmith, Steven
    Simegn, Mengistu
    Mesiha, Nancy
    Sharma, Rajaninder
    [J]. JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S25 - S25
  • [18] EFFECT OF TORSEMIDE VS FUROSEMIDE ON CLINICAL, LABORATORY, RADIOGRAPHIC, AND QUALITY OF LIFE VARIABLES IN DOGS WITH HEART FAILURE
    Peddle, G. D.
    Oyama, M. A.
    Singletary, G. E.
    Reynolds, C. A.
    Trafny, D. J.
    Machen, M. C.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2011, 25 (03) : 659 - 659
  • [19] Three and Five-Year Outcomes for Teduglutide in Intestinal Failure
    Puello, Frances
    Wall, Elizabeth
    Herlitz, Jean
    Lozano, Scott
    Reynolds, Valerie
    Widlicka, Annie
    McDonald, Edwin K.
    Semrad, Carol
    Micic, Dejan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S671 - S671
  • [20] Five-Year Outcomes in Patients Hospitalized With Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction in the Medicare Population
    Shah, Kevin S.
    Xu, Haolin
    Matsouaka, Roland A.
    Bhatt, Deepak L.
    Heidenreich, Paul A.
    Hernandez, Adran F.
    Devore, Adam D.
    Yancy, Clyde W.
    Fonarow, Gregg C.
    [J]. CIRCULATION, 2017, 136